Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Zocor 40mg

This product is the most expensive of its product family


Contraindicated
Reduce the foetal levels of mevalonate (precursor of cholesterol biosynthesis)

Contraindicated
Zocor 40mg :
Type Medicine Authorised
Originator B
Agent Droguerie de l'Union
Distributor Droguerie de l'Union
Laboratory MSD
Manufacturer Algorithm Pharmaceutical Manufacturers
Manufacturing Type Under license from Merck and Co USA
Origin Lebanon
ATC C10AA01

Your comment will appear shortly after approval

Zocor 40mg :

Revision Date : 01/09/2015


Effect Frequency
Abdominal pain Rare
Alopecia Rare
ALT increased Rare
Anaemia Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Arthralgia (Pain joint) (Joint ache) Not known
Arthritis Not known
AST increased Rare
Asthenia Rare
Blood alkaline phosphatase increased Rare
Blood creatine phosphokinase increased Rare
Cephalea Rare
Cognitive impairment (Cognitive disturbance) Very rare
Constipation Rare
Depression Not known
Dermatomyositis Not known
Diarrhoea (Diarrhea) Rare
Dyspepsia Rare
Dyspnoea (dyspnea) Not known
Eosinophilia Not known
Erectile dysfunction Not known
erythrocyte sedimentation rate (ESR) increased Not known
Fasting hyperglycaemia Not known
Fever Not known
Flatulence Rare
Flushing Not known
Gamma-GT increased Rare
Glycosylated haemoglobin increased Not known
Hepatic failure (Hepatic insufficiency) (Liver failure) Very rare
Hepatitis Rare
Hypersensitivity reactions Rare
Immune-mediated necrotising myopathy Very rare
Insomnia Very rare
Interstitial pneumonitis Not known
Jaundice Rare
Lupus syndrome Not known
Malaise Not known
Memory impairment Very rare
Muscle cramps Rare
Myalgia Rare
Myopathy Rare
Myositis Rare
Nausea Rare
Neuropathy peripheral Rare
Pancreatitis Rare
Paraesthesia (paresthesia) Rare
Photosensitivity Not known
Polymyalgia rheumatica Not known
Pruritus Rare
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Rare
Rhabdomyolysis Rare
Skin rash Rare
Tendon rupture Not known
Tendonopathy Not known
Thrombocytopenia (Thrombopenia) Not known
Urticaria Not known
Vasculitides Not known
Vertigo Rare
Vomiting Rare

Different Units By MoH Code

Revision Date : 01/02/2016

Zocor 40mg  MoH 6729 :
Form Tablet
Package Size Box of 30
Strength 40mg
Storage Condition 15-30°C In the original container
Public Price 1435991.7 L.L.
Stratum A2
NSSF ✔
Quarantine ✘
Reg. Number 97663/11
Submission date 01/01/2011
Registration Year 2012


Price Comparison

● Country: Denmark
● Package Size: 98
● Public Price: 1324.75 DKK ( 17,189,956.00 LBP )
● Pack size unit used: 98
● Cost/Unit: 13,5179 DKK ( 168,688.00 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Non Marketed

● Country: Tunisia
● Package Size: 28
● Public Price: 144.7 TND ( 4,176,765.50 LBP )
● Pack size unit used: 28
● Cost/Unit: 5,1679 TND ( 144,325.00 LBP )
● Pricing Date: 04/02/2019
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 30
● Public Price: 169 QAR ( 4,150,302.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 5,6333 QAR ( 122,790.00 LBP )
● Pharmacy Price: 138.47466503 QAR ( 3400660.8238067 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 30
● Public Price: 166.5 AED ( 4,022,806.50 LBP )
● Pack size unit used: 30
● Cost/Unit: 5,55 AED ( 120,805.00 LBP )
● Pharmacy Price: 134.22 AED ( 3242889.42 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 30's (10's Blister x 3)
● Public Price: 166.5 AED ( 4,022,806.50 LBP )
● Pack size unit used: 30
● Cost/Unit: 5,55 AED ( 120,805.00 LBP )
● Pharmacy Price: 134.22 AED ( 3242889.42 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: KSA
● Package Size: 30
● Public Price: 150.8 SAR ( 3,564,912.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 5,0267 SAR ( 118,200.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 28
● Public Price: 29.69 GBP ( 3,374,238.81 LBP )
● Pack size unit used: 28
● Cost/Unit: 1,0604 GBP ( 113,649.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 28
● Public Price: 39.55 CHF ( 4,090,261.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 1,4125 CHF ( 103,420.00 LBP )
● Exfactory Price: 20.16 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 30
● Public Price: 1435991.7 LBP ( 1,435,991.70 LBP )
● Pack size unit used: 30
● Cost/Unit: 47866,39 LBP ( 47,866.00 LBP )
● Pricing Date: 13/06/2024

● Country: Norway
● Package Size: 98
● Public Price: 544.6 NOK ( 4,413,438.40 LBP )
● Pack size unit used: 98
● Cost/Unit: 5,5571 NOK ( 40,520.00 LBP )
● Pharmacy Price: 398.67 NOK ( 3230821.68 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Argentina
● Package Size: 30
● Public Price: 1039.94 ARS ( 99,834.24 LBP )
● Pack size unit used: 30
● Cost/Unit: 34,6647 ARS ( 3,264.00 LBP )
● Reference: Ministerio de Salud
● Pricing Date: 13/05/2019
● Type: Medicine Authorised

● Country: Italy
● Package Size: 28UNITA
● Public Price: 11.11 EUR ( 1,076,292.36 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,3968 EUR ( 0.00 LBP )
● Pricing Date: 15/01/2021
● Type: Medicine Authorised

● Country: Ireland
● Package Size: 28
● Public Price: 5.04 EUR ( 488,255.04 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,18 EUR ( 0.00 LBP )
● Exfactory Price: 5 EUR
● Pricing Date: 09/10/2020
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 28
● Public Price: 13.14 EUR ( 1,272,950.64 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,4693 EUR ( 0.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 01/06/2018
● Type: Medicine Non Marketed

● Country: Belgium
● Package Size: 98
● Public Price: 20.53 EUR ( 1,988,864.28 LBP )
● Pack size unit used: 98
● Cost/Unit: 0,2095 EUR ( 0.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 30
● Public Price: 7.21 JOD ( 902,843.41 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,2403 JOD ( 0.00 LBP )
● Pharmacy Price: 5.5 JOD ( 688715.5 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 30
● Public Price: 16.18 BHD ( 3,846,536.12 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,5393 BHD ( 0.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 30
● Public Price: 12.87 EUR ( 1,246,794.12 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,429 EUR ( 0.00 LBP )
● Pharmacy Price: 5.87 EUR ( 568662.12 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Germany
● Package Size: 100
● Public Price: 76.43 EUR ( 7,404,232.68 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,7643 EUR ( 0.00 LBP )
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Kuweit
● Package Size: Boîte de 30
● Public Price: 13.83 KWD ( 4,060,225.23 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,461 KWD ( 0.00 LBP )
● Pharmacy Price: 11.68 KWD ( 3429026.08 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

● Country: Spain
● Package Size: 28
● Public Price: 12.11 EUR ( 1,173,168.36 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,4325 EUR ( 0.00 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Non Marketed

● Country: Greece
● Package Size: 10
● Public Price: 4.36 EUR ( 422,379.36 LBP )
● Pack size unit used: 10
● Cost/Unit: 0,436 EUR ( 0.00 LBP )
● Exfactory Price: 3.01 EUR
● Pharmacy Price: 3.16 EUR ( 306128.16 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 28
● Public Price: 23.47 TRY ( 62,899.60 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,8382 TRY ( 0.00 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: Finland
● Package Size: 98
● Public Price: 79.85 EUR ( 7,735,548.60 LBP )
● Pack size unit used: 98
● Cost/Unit: 0,8148 EUR ( 0.00 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: France
● Package Size: 28
● Public Price: 5.97 EUR ( 578,349.72 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2132 EUR ( 0.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Homozygous familial hypercholesterolemia :
● Cost/Unit: 13,5179 DKK ( 168,688.00 LBP )
● Cost/Day: 13,52 DKK ( 168,688.00 LBP )
● Cost/Month: 405,6 DKK ( 5,255,280.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 13,5179 DKK ( 168,688.00 LBP )
● Cost/Day: 13,52 DKK ( 168,688.00 LBP )
● Cost/Month: 405,6 DKK ( 5,255,280.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 13,5179 DKK ( 168,688.00 LBP )
● Cost/Day: 13,52 DKK ( 168,688.00 LBP )
● Cost/Month: 405,6 DKK ( 5,255,280.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 5,1679 TND ( 144,325.00 LBP )
● Cost/Day: 5,17 TND ( 144,325.00 LBP )
● Cost/Month: 155,1 TND ( 4,474,075.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 5,1679 TND ( 144,325.00 LBP )
● Cost/Day: 5,17 TND ( 144,325.00 LBP )
● Cost/Month: 155,1 TND ( 4,474,075.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 5,1679 TND ( 144,325.00 LBP )
● Cost/Day: 5,17 TND ( 144,325.00 LBP )
● Cost/Month: 155,1 TND ( 4,474,075.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 5,6333 QAR ( 122,790.00 LBP )
● Cost/Day: 5,63 QAR ( 122,790.00 LBP )
● Cost/Month: 168,9 QAR ( 4,125,744.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 5,6333 QAR ( 122,790.00 LBP )
● Cost/Day: 5,63 QAR ( 122,790.00 LBP )
● Cost/Month: 168,9 QAR ( 4,125,744.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 5,6333 QAR ( 122,790.00 LBP )
● Cost/Day: 5,63 QAR ( 122,790.00 LBP )
● Cost/Month: 168,9 QAR ( 4,125,744.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 5,55 AED ( 120,805.00 LBP )
● Cost/Day: 5,55 AED ( 120,805.00 LBP )
● Cost/Month: 166,5 AED ( 4,010,726.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 5,55 AED ( 120,805.00 LBP )
● Cost/Day: 5,55 AED ( 120,805.00 LBP )
● Cost/Month: 166,5 AED ( 4,010,726.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 5,55 AED ( 120,805.00 LBP )
● Cost/Day: 5,55 AED ( 120,805.00 LBP )
● Cost/Month: 166,5 AED ( 4,010,726.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 5,55 AED ( 120,805.00 LBP )
● Cost/Day: 5,55 AED ( 120,805.00 LBP )
● Cost/Month: 166,5 AED ( 4,010,726.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 5,55 AED ( 120,805.00 LBP )
● Cost/Day: 5,55 AED ( 120,805.00 LBP )
● Cost/Month: 166,5 AED ( 4,010,726.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 5,55 AED ( 120,805.00 LBP )
● Cost/Day: 5,55 AED ( 120,805.00 LBP )
● Cost/Month: 166,5 AED ( 4,010,726.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 5,0267 SAR ( 118,200.00 LBP )
● Cost/Day: 5,03 SAR ( 118,200.00 LBP )
● Cost/Month: 150,9 SAR ( 3,546,000.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 5,0267 SAR ( 118,200.00 LBP )
● Cost/Day: 5,03 SAR ( 118,200.00 LBP )
● Cost/Month: 150,9 SAR ( 3,546,000.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 5,0267 SAR ( 118,200.00 LBP )
● Cost/Day: 5,03 SAR ( 118,200.00 LBP )
● Cost/Month: 150,9 SAR ( 3,546,000.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 1,0604 GBP ( 113,649.00 LBP )
● Cost/Day: 1,06 GBP ( 113,649.00 LBP )
● Cost/Month: 31,8 GBP ( 3,523,119.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 1,0604 GBP ( 113,649.00 LBP )
● Cost/Day: 1,06 GBP ( 113,649.00 LBP )
● Cost/Month: 31,8 GBP ( 3,523,119.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 1,0604 GBP ( 113,649.00 LBP )
● Cost/Day: 1,06 GBP ( 113,649.00 LBP )
● Cost/Month: 31,8 GBP ( 3,523,119.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 1,4125 CHF ( 103,420.00 LBP )
● Cost/Day: 1,41 CHF ( 103,420.00 LBP )
● Cost/Month: 42,3 CHF ( 4,343,640.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 1,4125 CHF ( 103,420.00 LBP )
● Cost/Day: 1,41 CHF ( 103,420.00 LBP )
● Cost/Month: 42,3 CHF ( 4,343,640.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 1,4125 CHF ( 103,420.00 LBP )
● Cost/Day: 1,41 CHF ( 103,420.00 LBP )
● Cost/Month: 42,3 CHF ( 4,343,640.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 47866,39 LBP ( 47,866.00 LBP )
● Cost/Day: 47866,39 LBP ( 47,866.00 LBP )
● Cost/Month: 1435991,7 LBP ( 1,435,991.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 47866,39 LBP ( 47,866.00 LBP )
● Cost/Day: 47866,39 LBP ( 47,866.00 LBP )
● Cost/Month: 1435991,7 LBP ( 1,435,991.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 47866,39 LBP ( 47,866.00 LBP )
● Cost/Day: 47866,39 LBP ( 47,866.00 LBP )
● Cost/Month: 1435991,7 LBP ( 1,435,991.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 5,5571 NOK ( 40,520.00 LBP )
● Cost/Day: 5,56 NOK ( 40,520.00 LBP )
● Cost/Month: 166,8 NOK ( 1,345,264.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 5,5571 NOK ( 40,520.00 LBP )
● Cost/Day: 5,56 NOK ( 40,520.00 LBP )
● Cost/Month: 166,8 NOK ( 1,345,264.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 5,5571 NOK ( 40,520.00 LBP )
● Cost/Day: 5,56 NOK ( 40,520.00 LBP )
● Cost/Month: 166,8 NOK ( 1,345,264.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 34,6647 ARS ( 3,264.00 LBP )
● Cost/Day: 34,66 ARS ( 3,264.00 LBP )
● Cost/Month: 1039,8 ARS ( 99,744.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 34,6647 ARS ( 3,264.00 LBP )
● Cost/Day: 34,66 ARS ( 3,264.00 LBP )
● Cost/Month: 1039,8 ARS ( 99,744.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 34,6647 ARS ( 3,264.00 LBP )
● Cost/Day: 34,66 ARS ( 3,264.00 LBP )
● Cost/Month: 1039,8 ARS ( 99,744.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,5393 BHD ( 0.00 LBP )
● Cost/Day: 0,54 BHD ( 0.00 LBP )
● Cost/Month: 16,2 BHD ( 3,803,744.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,5393 BHD ( 0.00 LBP )
● Cost/Day: 0,54 BHD ( 0.00 LBP )
● Cost/Month: 16,2 BHD ( 3,803,744.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,5393 BHD ( 0.00 LBP )
● Cost/Day: 0,54 BHD ( 0.00 LBP )
● Cost/Month: 16,2 BHD ( 3,803,744.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,8382 TRY ( 0.00 LBP )
● Cost/Day: 0,84 TRY ( 0.00 LBP )
● Cost/Month: 25,2 TRY ( 67,000.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,8382 TRY ( 0.00 LBP )
● Cost/Day: 0,84 TRY ( 0.00 LBP )
● Cost/Month: 25,2 TRY ( 67,000.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,8382 TRY ( 0.00 LBP )
● Cost/Day: 0,84 TRY ( 0.00 LBP )
● Cost/Month: 25,2 TRY ( 67,000.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,2095 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 581,256.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,2095 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 581,256.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,2095 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 581,256.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,4693 EUR ( 0.00 LBP )
● Cost/Day: 0,47 EUR ( 0.00 LBP )
● Cost/Month: 14,1 EUR ( 1,356,264.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,4693 EUR ( 0.00 LBP )
● Cost/Day: 0,47 EUR ( 0.00 LBP )
● Cost/Month: 14,1 EUR ( 1,356,264.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,4693 EUR ( 0.00 LBP )
● Cost/Day: 0,47 EUR ( 0.00 LBP )
● Cost/Month: 14,1 EUR ( 1,356,264.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,461 KWD ( 0.00 LBP )
● Cost/Day: 0,46 KWD ( 0.00 LBP )
● Cost/Month: 13,8 KWD ( 3,816,553.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,461 KWD ( 0.00 LBP )
● Cost/Day: 0,46 KWD ( 0.00 LBP )
● Cost/Month: 13,8 KWD ( 3,816,553.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,461 KWD ( 0.00 LBP )
● Cost/Day: 0,46 KWD ( 0.00 LBP )
● Cost/Month: 13,8 KWD ( 3,816,553.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,18 EUR ( 0.00 LBP )
● Cost/Day: 0,18 EUR ( 0.00 LBP )
● Cost/Month: 5,4 EUR ( 484,380.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,18 EUR ( 0.00 LBP )
● Cost/Day: 0,18 EUR ( 0.00 LBP )
● Cost/Month: 5,4 EUR ( 484,380.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,18 EUR ( 0.00 LBP )
● Cost/Day: 0,18 EUR ( 0.00 LBP )
● Cost/Month: 5,4 EUR ( 484,380.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,2403 JOD ( 0.00 LBP )
● Cost/Day: 0,24 JOD ( 0.00 LBP )
● Cost/Month: 7,2 JOD ( 876,547.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,2403 JOD ( 0.00 LBP )
● Cost/Day: 0,24 JOD ( 0.00 LBP )
● Cost/Month: 7,2 JOD ( 876,547.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,2403 JOD ( 0.00 LBP )
● Cost/Day: 0,24 JOD ( 0.00 LBP )
● Cost/Month: 7,2 JOD ( 876,547.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,3968 EUR ( 0.00 LBP )
● Cost/Day: 0,4 EUR ( 0.00 LBP )
● Cost/Month: 12 EUR ( 1,162,512.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,3968 EUR ( 0.00 LBP )
● Cost/Day: 0,4 EUR ( 0.00 LBP )
● Cost/Month: 12 EUR ( 1,162,512.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,3968 EUR ( 0.00 LBP )
● Cost/Day: 0,4 EUR ( 0.00 LBP )
● Cost/Month: 12 EUR ( 1,162,512.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,2132 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 581,256.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,2132 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 581,256.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,2132 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 581,256.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,8148 EUR ( 0.00 LBP )
● Cost/Day: 0,81 EUR ( 0.00 LBP )
● Cost/Month: 24,3 EUR ( 2,325,024.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,8148 EUR ( 0.00 LBP )
● Cost/Day: 0,81 EUR ( 0.00 LBP )
● Cost/Month: 24,3 EUR ( 2,325,024.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,8148 EUR ( 0.00 LBP )
● Cost/Day: 0,81 EUR ( 0.00 LBP )
● Cost/Month: 24,3 EUR ( 2,325,024.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,436 EUR ( 0.00 LBP )
● Cost/Day: 0,44 EUR ( 0.00 LBP )
● Cost/Month: 13,2 EUR ( 1,259,388.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,436 EUR ( 0.00 LBP )
● Cost/Day: 0,44 EUR ( 0.00 LBP )
● Cost/Month: 13,2 EUR ( 1,259,388.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,436 EUR ( 0.00 LBP )
● Cost/Day: 0,44 EUR ( 0.00 LBP )
● Cost/Month: 13,2 EUR ( 1,259,388.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,4325 EUR ( 0.00 LBP )
● Cost/Day: 0,43 EUR ( 0.00 LBP )
● Cost/Month: 12,9 EUR ( 1,162,512.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,4325 EUR ( 0.00 LBP )
● Cost/Day: 0,43 EUR ( 0.00 LBP )
● Cost/Month: 12,9 EUR ( 1,162,512.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,4325 EUR ( 0.00 LBP )
● Cost/Day: 0,43 EUR ( 0.00 LBP )
● Cost/Month: 12,9 EUR ( 1,162,512.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,7643 EUR ( 0.00 LBP )
● Cost/Day: 0,76 EUR ( 0.00 LBP )
● Cost/Month: 22,8 EUR ( 2,131,272.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,7643 EUR ( 0.00 LBP )
● Cost/Day: 0,76 EUR ( 0.00 LBP )
● Cost/Month: 22,8 EUR ( 2,131,272.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,7643 EUR ( 0.00 LBP )
● Cost/Day: 0,76 EUR ( 0.00 LBP )
● Cost/Month: 22,8 EUR ( 2,131,272.00 LBP )
Homozygous familial hypercholesterolemia :
● Cost/Unit: 0,429 EUR ( 0.00 LBP )
● Cost/Day: 0,43 EUR ( 0.00 LBP )
● Cost/Month: 12,9 EUR ( 1,162,512.00 LBP )
Hypercholesterolemia : (Adults)
● Cost/Unit: 0,429 EUR ( 0.00 LBP )
● Cost/Day: 0,43 EUR ( 0.00 LBP )
● Cost/Month: 12,9 EUR ( 1,162,512.00 LBP )
Reduction of cardiovascular mortality and morbidity :
● Cost/Unit: 0,429 EUR ( 0.00 LBP )
● Cost/Day: 0,43 EUR ( 0.00 LBP )
● Cost/Month: 12,9 EUR ( 1,162,512.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info